Keto-on-the-Clock: A Survey of Dietetic Care Contact Time Taken to Provide Ketogenic Diets for Drug-Resistant Epilepsy in the UK

被引:3
|
作者
Lambert, Bridget [1 ]
Lightfoot, Kathryn [2 ]
Meskell, Rachel [2 ]
Whiteley, Victoria J. [3 ,4 ]
Martin-McGill, Kirsty J. [5 ]
Schoeler, Natasha E. [6 ]
机构
[1] Vitaflo Int Ltd, 182 Sefton St, Liverpool L3 4BQ, Merseyside, England
[2] Leeds Childrens Hosp, 2nd Floor,2 Pk Lane, Leeds LS3 1ES, W Yorkshire, England
[3] Royal Manchester Childrens Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England
[4] Univ Salford, Sch Hlth & Soc, 43 Crescent, Manchester M5 4WT, Lancs, England
[5] Univ Chester, Dept Clin Sci & Nutr, Parkgate Rd, Chester CH1 4BJ, Cheshire, England
[6] UCL Great Ormond St Inst Child Hlth, 30 Guildford St, London WC1N 1EH, England
关键词
ketogenic diets; dietitian; drug-resistant epilepsy; patient contact; time; dietetic management; EFFICACY;
D O I
10.3390/nu13082484
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Medical ketogenic diets (KDs) are effective yet resource-intensive treatment options for drug-resistant epilepsy (DRE). We investigated dietetic care contact time, as no recent data exist. An online survey was circulated to ketogenic dietitians in the UK and Ireland. Data were collected considering feeding route, KD variant and type of ketogenic enteral feed (KEF), and the estimated number of hours spent on patient-related activities during the patient journey. Fifteen dietitians representing nine KD centres responded. Of 335 patients, 267 (80%) were 18 years old or under. Dietitians spent a median of 162 h (IQR 54) of care contact time per patient of which a median of 48% (IQR 6) was direct contact. Most time was required for the classical KD taken orally (median 193 h; IQR 213) as a combined tube and oral intake (median 211 h; IQR 172) or a blended food KEF (median 189 h; IQR 148). Care contact time per month was higher for all KDs during the three-month initial trial compared to the two-year follow-up stage. Patients and caregivers with characteristics such as learning or language difficulties were identified as taking longer. Twelve out of fifteen (80%) respondents managed patients following the KD for more than two years, requiring an estimated median contact care time of 2 h (IQR 2) per patient per month. Ten out of fifteen (67%) reported insufficient official hours for dietetic activities. Our small survey gives insight into estimated dietetic care contact time, with potential application for KD provision and service delivery
引用
收藏
页数:11
相关论文
共 10 条
  • [1] Ketogenic Diets for Drug-Resistant Epilepsy
    Covey, Carlton
    [J]. AMERICAN FAMILY PHYSICIAN, 2021, 103 (09) : 524 - 525
  • [2] Ketogenic diets for drug-resistant epilepsy
    Martin-McGill, Kirsty J.
    Bresnahan, Rebecca
    Levy, Robert G.
    Cooper, Paul N.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [3] Ketogenic diets for drug-resistant epilepsy
    Martin-McGill, Kirsty J.
    Jackson, Cerian F.
    Bresnahan, Rebecca
    Levy, Robert G.
    Cooper, Paul N.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (11):
  • [4] What are the effects of ketogenic diets on drug-resistant epilepsy? A Cochrane Review summary with commentary
    Arman, Sina
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2020, 62 (10): : 1121 - 1123
  • [5] The Efficacy and Safety of Ketogenic Diets in Drug-Resistant Epilepsy in Children and Adolescents: a Systematic Review of Randomized Controlled Trials
    Evangelia Desli
    Martha Spilioti
    Athanasios Evangeliou
    Foteinos Styllas
    Faidon Magkos
    Maria Dalamaga
    [J]. Current Nutrition Reports, 2022, 11 : 102 - 116
  • [6] The Efficacy and Safety of Ketogenic Diets in Drug-Resistant Epilepsy in Children and Adolescents: a Systematic Review of Randomized Controlled Trials
    Desli, Evangelia
    Spilioti, Martha
    Evangeliou, Athanasios
    Styllas, Foteinos
    Magkos, Faidon
    Dalamaga, Maria
    [J]. CURRENT NUTRITION REPORTS, 2022, 11 (02) : 102 - 116
  • [7] Telemedicine, drug-resistant epilepsy, and ketogenic dietary therapies: A patient survey of a pediatric remote-care program during the COVID-19 pandemic
    Semprino, Marcos
    Fasulo, Lorena
    Fortini, Sebastian
    Martorell Molina, Catalina Isabel
    Gonzalez, Lara
    Alejandra Ramos, Paola
    Martinez, Carolina
    Caraballo, Roberto
    [J]. EPILEPSY & BEHAVIOR, 2020, 112
  • [8] The use of ketogenic diets in children living with drug-resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review
    Cameron, Tracy
    Allan, Karen
    [J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2024, 37 (04) : 827 - 846
  • [9] Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial
    Schoeler, Natasha E.
    Marston, Louise
    Lyons, Laura
    Halsall, Sally
    Jain, Ruchika
    Titre-Johnson, Siobhan
    Balogun, Maryam
    Heales, Simon J. R.
    Eaton, Simon
    Orford, Michael
    Neal, Elizabeth
    Reilly, Colin
    Eltze, Christin
    Stephen, Elma
    Mallick, Andrew A.
    O'Callaghan, Finbar
    Agrawal, Shakti
    Parker, Alasdair
    Kirkpatrick, Martin
    Brunklaus, Andreas
    McLellan, Ailsa
    McCullagh, Helen
    Samanta, Rajib
    Kneen, Rachel
    Tan, Hui Jeen
    Devlin, Anita
    Prasad, Manish
    Rattihalli, Rohini
    Basu, Helen
    Desurkar, Archana
    Williams, Ruth
    Fallon, Penny
    Nazareth, Irwin
    Freemantle, Nick
    Cross, J. Helen
    [J]. LANCET NEUROLOGY, 2023, 22 (12): : 1113 - 1124
  • [10] Physician distress when treatments fail. Survey on physician distress when treating persons with drug-resistant epilepsy and knowledge of neuropalliative care
    Drees, Cornelia
    Hixon, Alison M.
    Sillau, Stefan
    Lopez-Esquibel, Natalie
    Spitz, Mark
    Mohler, Ryan
    Baca, Christine
    Fetrow, Kirsten
    Brown, Mesha-Gay
    Vaughan, Christina
    [J]. EPILEPSY & BEHAVIOR, 2023, 140